Illustration: Natalie Peeples/Axios
Apollo Global Management agreed to buy a minority stake in Bayer's contraceptives business for $3.43 billion, the companies said Friday.The big picture: It's the latest reshuffling of reproductive health assets as investors and Big Pharma weigh their broader women's health strategies.
